Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
$2.91
-1.4%
$3.06
$2.63
$205.20
$39.48M1.916,125 shs2,909 shs
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
$3.67
-2.1%
$3.99
$3.40
$6.46
$124.79M1.275,279 shs22,499 shs
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$7.95
+0.5%
$8.57
$6.94
$18.05
$143.75M0.8375,529 shs46,884 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$2.95
-3.0%
$5.48
$2.81
$21.41
$161.12M-0.25328,832 shs265,725 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
-1.36%+1.39%+2.83%-15.41%-94.79%
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
-2.11%-5.87%-4.65%+4.89%-35.37%
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
+0.25%-4.22%-7.77%-21.21%-51.20%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-2.96%-23.58%-28.22%-70.85%-77.01%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
$2.91
-1.4%
$3.06
$2.63
$205.20
$39.48M1.916,125 shs2,909 shs
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
$3.67
-2.1%
$3.99
$3.40
$6.46
$124.79M1.275,279 shs22,499 shs
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$7.95
+0.5%
$8.57
$6.94
$18.05
$143.75M0.8375,529 shs46,884 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$2.95
-3.0%
$5.48
$2.81
$21.41
$161.12M-0.25328,832 shs265,725 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
-1.36%+1.39%+2.83%-15.41%-94.79%
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
-2.11%-5.87%-4.65%+4.89%-35.37%
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
+0.25%-4.22%-7.77%-21.21%-51.20%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-2.96%-23.58%-28.22%-70.85%-77.01%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
1.50
ReduceN/AN/A
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
2.00
Hold$4.008.96% Upside
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
2.00
HoldN/AN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest ARBK, ZSQR, TRAK, and SANG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/21/2026
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
Reiterated RatingSell (D)
8/17/2026
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
UpgradeSell (E+)Sell (D-)
8/14/2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
DowngradeSell (D-)Sell (E-)
8/3/2026
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
UpgradeStrong SellHold
7/31/2026
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
DowngradeSell (D-)Sell (E+)
7/31/2026
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
DowngradeHold (C)Hold (C-)
7/15/2026
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
UpgradeSell (E+)Sell (D-)
7/15/2026
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
UpgradeHold (C-)Hold (C)
7/3/2026
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
DowngradeHoldStrong Sell
6/26/2026
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
DowngradeSell (D-)Sell (E+)
(Data available from 9/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
$15.52M2.51$0.61 per share4.80$0.97 per share3.00
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
$236.69M0.52$0.96 per share3.83$7.65 per share0.48
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$22.61M6.39$0.46 per share17.43$2.71 per share2.93
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$1.36M114.96N/AN/A$2.50 per share1.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
$5.08M-$117.39N/AN/AN/AN/AN/AN/AN/A
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
-$5.01M-$0.19N/A367.10N/A-3.04%-2.26%-1.71%9/16/2026 (Estimated)
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$6.98M$0.3721.49N/AN/A30.75%14.44%12.85%N/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-$11.92M-$1.63N/AN/AN/A-773.72%-49.45%-46.88%N/A

Latest ARBK, ZSQR, TRAK, and SANG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/16/2026Q4 2026
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
-$0.06N/AN/AN/A$51.27 millionN/A
8/13/2026Q2 2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A-$0.28N/A-$0.28N/A$1.58 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
N/AN/AN/AN/AN/A
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
N/AN/AN/AN/AN/A
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
$0.081.01%N/A21.62%2 Years
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/AN/AN/AN/AN/A

Latest ARBK, ZSQR, TRAK, and SANG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/18/2026
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
quarterly$0.020.89%6/30/20266/30/20268/14/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
0.14
0.51
0.51
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
0.07
0.90
0.74
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
N/A
4.89
4.89
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A
7.66
7.66

Institutional Ownership

CompanyInstitutional Ownership
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
2.42%
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
39.65%
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
27.35%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
13.88%

Insider Ownership

CompanyInsider Ownership
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
N/A
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
14.00%
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
41.00%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
24.25%
CompanyEmployeesShares OutstandingFree FloatOptionable
Argo Blockchain PLC Sponsored ADR stock logo
ARBK
Argo Blockchain
4013.36 million13.36 millionNo Data
Sangoma Technologies Corporation stock logo
SANG
Sangoma Technologies
73033.28 million28.62 millionNot Optionable
ReposiTrak Inc. stock logo
TRAK
ReposiTrak
7018.17 million10.72 millionN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
253.00 million40.15 millionNot Optionable

Recent News About These Companies

Z Squared Inc. Provides Capital Structure Update

New MarketBeat Followers Over Time

Media Sentiment Over Time

Argo Blockchain stock logo

Argo Blockchain NASDAQ:ARBK

$2.91 -0.04 (-1.36%)
As of 09/4/2026 03:59 PM Eastern

Argo Blockchain plc, together with its subsidiaries, engages in the bitcoin and other cryptocurrencies mining business worldwide. It engages in mining purpose-built computers for complex cryptographic algorithms. The company was formerly known as GoSun Blockchain Limited and changed its name to Argo Blockchain plc in December 2017. Argo Blockchain plc was incorporated in 2017 and is based in London, the United Kingdom.

Sangoma Technologies stock logo

Sangoma Technologies NASDAQ:SANG

$3.67 -0.08 (-2.11%)
As of 09/4/2026 03:56 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Sangoma Technologies Corporation develops, manufactures, distributes, and supports voice and data connectivity components for software-based communication applications worldwide. The company offers Switchvox, a voice over internet protocol phone system; Switchvox Cloud, a unified communications solution, as well as provides cloud communication solutions. It offers SIP Trunking, a telephone service for one or multiple locations; PBXact Cloud, a centralized internet based solution; Asterisk and FreePBX, an open source IP PBX software; and FAXStation, a fax-over-IP solution. In addition, the company provides desk phone, DECT phones, and headset related products. Further, it offers VoIP gateways, session border controllers, telephony card, and managed service provider services. Sangoma Technologies Corporation was founded in 1984 and is headquartered in Markham, Canada.

ReposiTrak stock logo

ReposiTrak NYSE:TRAK

$7.95 +0.04 (+0.51%)
As of 09/4/2026 03:57 PM Eastern

Park City Group, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company is headquartered in Murray, Utah.

Coeptis Therapeutics stock logo

Coeptis Therapeutics NASDAQ:ZSQR

$2.95 -0.09 (-2.96%)
As of 09/4/2026 04:00 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.